
265: Novavax's CEO promises a turnaround & how Lilly roiled the obesity market
The Readout Loud
00:00
Novavax's Success During the Pandemic Turned Its Fortunes Around
I was curious for what the actual vibe of the conference was. ADA is not like ASCO or some of the like, I don't know, glitzy conferences that often are host to huge data sets and lots of journalistic coverage. This was like the eyes of the drug development world and the world beyond it because of the popularity of these medicines were very much on ADA. There's been a lot of excitement among the doctors and researchers who attended.
Transcript
Play full episode